https://www.marketscreener.com/quote/stock/NICOX-SA-25281955/news/Nicox-Licensee-Bausch-Lomb-Receives-Approval-for-VYZULTA-latanoprostene-bunod-ophthalmic-solu-35697457/?utm_source=telegram&utm_medium=social&utm_campaign=share